Search
Powered By HealthLine
Special Offers
Health Tools
 Bipolar Basics
 Depression Treatment
 Depression Support Groups
 Anxiety Symptoms
 Quiz: Depression Basics
Featured Conditions
 Schizophrenia
 Anxiety
 Depression
 Bipolar
Resources
Healthscout News
3D Health Animations
Health Videos
Quizzes & Tools
Health Encyclopedia
In-Depth Reports
Library & Communities
News Archive
Drug Library
Find a Therapist
Enter City or Zip Code:
Powered by Psychology Today
PR Newswire
 Read latest







Channels
Home |  Today | Women| Men| Kids| Seniors| Diseases| Addictions| Sex & Relationships| Diet, Fitness, Looks| Alternative Medicine| Drug Checker
 Printer Friendly  Send to a Friend

Cocaine Addiction Vaccine Shows Some Success

Shot produced desired antibodies in some, but effects were fleeting, scientists say

By Amanda Gardner
HealthDay Reporter


Related Encyclopedia
 border=
Acne
Angina Pectoris
Angiogram
Angioplasty
More...

Related Healthscout Videos
 border=
Pinpointing Mental Illness
Body Dysmorphic Disorder- A Serious Disease
Body Dysmorphic Disorder- A Serious Disease
Stents for Emphysema
More...

Related Drug Information
 border=
Adderal XR
Concerta
Effexor XR
Paxil
More...

Related News Articles
 border=
New Generation of Healing: Genes to the Rescue
White Women More at Risk for Restless Legs
Folate Levels in Pregnancy Tied to ADHD in Offspring
Depression May Blur Memory of Aches and Pains
More...

MONDAY, Oct. 5 (HealthDay News) -- A vaccine to help cocaine addicts beat their habit is showing some effect but is far from a cure, researchers report.

Slightly more than one-third of participants in a new study developed desired immune system antibodies to the illicit drug and, in this group, cocaine use did go down. But the effects were only sustained for two months, the researchers found.

Text Continues Below



Experts were heartened by the finding but still circumspect in predicting how they might benefit active addicts.

"The results are promising, to be sure, but still the majority of participants did not respond," said Jeffrey T. Parsons, professor and chair of psychology at Hunter College in New York City. "It's also important to point out that all participants were also on methadone maintenance and cognitive behavioral therapy, so the best possible role this vaccine could play in the future of the treatment of cocaine addiction is as a part of a series of intervention efforts. The vaccine by itself is not likely to have strong effects, unless coupled with other forms of treatment."

"It's not the cure or the treatment but it's a good way to go," added Jean Bidlack, professor of pharmacology and physiology at the University of Rochester Medical Center.

And several major shortcomings still need to be worked out, such as the role of booster shots to keep up needed level of antibodies, pointed out Dr. Steven Prenzlauer, assistant professor of psychiatry and behavioral science at Texas A&M Health Science Center College of Medicine, Round Rock, and director of psychiatry and behavioral health at Lone Star Circle of Care.

Still, Dr. Nora Volkow, director of the U.S. National Institute on Drug Abuse, said during an afternoon press conference: "These findings are transformative in their ability to show for the first time positive results in cocaine addiction. This may be a promising approach as a strategy to address other types of drug addiction. This opens up a series of new opportunities."

Page:  1 | 2 | 3 | Next >>

Copyright © 2009 ScoutNews, LLC. All rights reserved.
Last updated 10/5/2009

Related Links
 border=
From Healthscout's partner site on depression, MyDepressionConnection.com
UNDERSTAND: Get a full understanding of depression
TREATMENT: Learn how therapy and lifestyle changes can help
DRUGS: Common drugs used to treat depression





SOURCES: Jeffrey T. Parsons, Ph.D., professor and chair of psychology, Hunter College, New York City; Steven Prenzlauer, M.D., assistant professor of psychiatry and behavioral science, Texas A&M Health Science Center College of Medicine, Round Rock, and director of psychiatry and behavioral health, Lone Star Circle of Care, Round Rock, Texas; Jean Bidlack, Ph.D., professor of pharmacology and physiology, University of Rochester Medical Center, Rochester, N.Y.; Nora Volkow, M.D., director, U.S. National Institute on Drug Abuse; Thomas Kosten, M.D., professor of psychiatry and neuroscience, Baylor College of Medicine, Houston; October 2009, Archives of General Psychiatry


About The HealthScout Network Contact Us
Copyright © 2001-2009. The HealthCentralNetwork, Inc. All rights reserved.
Privacy Policy: Updated as of April 1, 2009  Terms of Service   Site Map
Advertising Policy